Ensign Peak Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.9M Buy
702,951
+203,195
+41% +$24.6M 0.12% 154
2026
Q1
$81.7M Buy
499,756
+117,554
+31% +$18.1M 0.15% 134
2025
Q4
$66.5M Sell
382,202
-259,832
-40% -$47.4M 0.12% 155
2025
Q3
$92.5M Buy
642,034
+77,645
+14% +$9.51M 0.15% 133
2025
Q2
$56.8M Sell
564,389
-25,010
-4% -$1.91M 0.1% 185
2025
Q1
$45M Buy
589,399
+60,350
+11% +$4.62M 0.09% 200
2024
Q4
$36.5M Buy
529,049
+44,928
+9% +$3.24M 0.06% 221
2024
Q3
$35.3M Buy
484,121
+125,092
+35% +$9.23M 0.06% 223
2024
Q2
$24.1M Buy
359,029
+17,455
+5% +$677K 0.04% 281
2024
Q1
$9.27M Buy
341,574
+271,564
+388% +$7.6M 0.02% 472
2023
Q4
$2.17M Buy
70,010
+4,340
+7% +$113K ﹤0.01% 885
2023
Q3
$1.66M Hold
65,670
﹤0.01% 897
2023
Q2
$1.39M Hold
65,670
﹤0.01% 1023
2023
Q1
$1.12M Sell
65,670
-233,553
-78% -$4.54M ﹤0.01% 1153
2022
Q4
$5.98M Buy
299,223
+88,100
+42% +$1.7M 0.01% 521
2022
Q3
$4.55M Buy
211,123
+49,426
+31% +$1.19M 0.01% 542
2022
Q2
$3.19M Buy
161,697
+116,937
+261% +$2.45M 0.01% 648
2022
Q1
$1.05M Buy
44,760
+16,600
+59% +$386K ﹤0.01% 1175
2021
Q4
$767K Buy
+28,160
New +$805K ﹤0.01% 1414

Other funds holding INSM

Ensign Peak Advisors's INSM Position: Q2 2026 in Review

Ensign Peak Advisors increased its Insmed (INSM) stake by 41% in Q2 2026, buying an estimated $24.6M and bringing the position to 702,951 shares worth $74.9M. The position accounts for 0.12% of the portfolio, ranked #154.

Ensign Peak Advisors first reported a position in INSM in Q4 2021 and has held it in 19 quarters since. The position peaked at $92.5M in Q3 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Ensign Peak Advisors held 702,951 shares of Insmed worth $74.9M as of Q2 2026.
  • Ensign Peak Advisors bought 203,195 Insmed shares in Q2 2026, an estimated $24.6M.
  • Insmed made up 0.12% of Ensign Peak Advisors's portfolio in Q2 2026, its #154 holding.
  • Ensign Peak Advisors first reported a position in Insmed in Q4 2021 and has held it in 19 quarters since.
  • Ensign Peak Advisors's Insmed position peaked at $92.5M in Q3 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.